Flatulence et vent
Revu par Dr Philippa Vincent, MRCGPDernière mise à jour par Dr Doug McKechnie, MRCGPLast updated 25 juin 2024
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
Professionnels de la santé
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Ventre ballonné, gaz et flatulences article more useful, or one of our other articles de santé.
Dans cet article:
Continuez à lire ci-dessous
What is flatulence and wind?
Flatulence and wind are symptoms related to gas in the gastrointestinal (GI) system. 'Flatulence' usually refers to gas passed per rectum. 'Wind' as a symptom may mean either belching (gas passed from the stomach outwards via the mouth - also called 'eructation') or gas passed per rectum (or even just feeling bloated).
Flatulence and belching are normal gut functions, but - culture- and context-dependent - are often seen as inappropriate, rude, or embarrassing. Excessive or distressing flatulence and belching are common symptoms.
Normal physiology
Retour au sommaireBelching12
This is the release of gas from the stomach, either voluntary or involuntary. It is a normal reflex which occurs most commonly after meals. Air is ingested with each swallow, though the exact amount varies. Ingested carbonated drinks also release gas in the stomach.
Excessive belching can be caused by:
Gastric belching, where gastric air is vented. This is a normal physiological process, but some conditions may cause excessive air venting, such as maladie de reflux gastro-œsophagien or functional dyspepsie. Aerophagia - excessive swallowing of air into the stomach - can also cause this, although people with aerophagia tend to report abdominal bloating and distension rather than excessive belching.3
Supragastric belching, where air is sucked into and expelled from the pharynx and oesophagus only.
Flatulence
Intestinal bacterial colonies produce gases. Carbon dioxide, hydrogen and methane are responsible for the main volume of intestinal gas and sulfur-containing gases for malodour.
The volume and composition of gas depends both on diet and on colonic flora.
Abdominal bloating and flatulence are common symptoms in le syndrome du côlon irritable (IBS). However, colonic gas production does not appear to be increased in people with IBS; instead, visceral hypersensitivity to gut stretch seems to be implicated in these symptoms.45
Continuez à lire ci-dessous
Causes of flatulence and wind (aetiology)
Retour au sommaireBelching
Diet/lifestyle factors - eg, eating too quickly, fizzy drinks, chewing gum, smoking.
Antacids - produce carbon dioxide gas which may contribute.
Dyspepsie ou reflux - patients may swallow air and may belch in an attempt to relieve upper GI symptoms.
Giardiase - can cause malodorous belching.
Learned behaviour - supragastric belching is essentially a learned behaviour, sometimes in response to other symptoms (eg, reflux, as above).6
Flatulence
Symptoms may be due to excessive volume of gas or to malodour. Possible causes or contributing factors are:
Diets high in fermentable carbohydrate (eg, pulses, bran and fruit).
Variations in bowel flora composition.
SII.
Aiguë gastro-entérite.
Small intestinal bacterial overgrowth.
Flatulence (and belching) are common in female runners. The cause is as yet unknown.78
Évaluation
Retour au sommaireClarify what most bothers the patient about their symptoms.
'Red flags' - eg, dysphagie, régime amaigrissant, sang dans les selles, persistent change in bowel habit, family history of cancer de l'intestin.9
Clinical examination (if relevant) to look for any serious signs - eg, l'anémie, nodes and abdominal, pelvic or rectal masses.
Continuez à lire ci-dessous
Diagnosing flatulence and wind (investigations)
Retour au sommaireThese depend on the clinical picture. Basic tests may be relevant to help rule out other problems (eg, as recommended in the diagnosis of SII):10
Hémogramme complet.
ESR or CRP.
Antibody testing for maladie cœliaque.
FIT testing should be offered if there are signs or symptoms suggestive of colorectal cancer.9
In specialist centres, oesophageal impedance monitoring can distinguish between gastric and supragastric belching, and may be useful if there is significant diagnostic doubt.1
Breath tests may be used to evaluate gut flora and small intestinal bacterial overgrowth.11
Management of flatulence and wind
Retour au sommaireBelching
Explanation of normal physiology and reassurance may be sufficient.
Speech therapy or behavioural therapy may be used; these often rely heavily on breathing exercises to prevent air suction into the oesophagus and supragastric belching.6
One small study of 12 patients reported improvement in belching and regurgitation symptoms from use of baclofen.12
Flatulence
Note that most of the research and literature on this topic relate to patients diagnosed with IBS. Possible treatments are:
Mild physical activity - has been shown to enhance gas clearance in a study of patients with bloating.
Treating exacerbating factors such as de la constipation.
Diet:
These are 'gut-friendly' bacteria such as lactobacilli and bifidobacteria.
Their mechanism of action is unclear but they can alter colonic fermentation and inhibit gas-producing bacteria such as Clostridium spp. They have an effect on intestinal motility and may also have an anti-inflammatory effect on mucosal cells.
They have been shown to modestly reduce symptoms in patients with IBS.14
The specific strain of bacteria may be important but, on current evidence, it is difficult to advise which strain(s) to use.
Probiotics should not be prescribed within the NHS, but can be purchased by patients elsewhere.15
Medications:
Antibiotics (eg, metronidazole or rifaximin) can be used to treat small intestinal bacterial overgrowth.16
Simeticone combined with loperamide may improve gas symptoms in acute diarrhoea.
Oral bismuth subsalicylate binds sulfide gases in the gut but is not safe for regular use due to the salicylate content.
Supplements:
Alpha-galactosidase, an enzyme supplement, has been shown to reduce flatus after eating beans, but there is insufficient evidence to support its regular use.17
Odour reduction devices:
Garment devices containing activated charcoal have been tested in one trial.18 This found that briefs containing charcoal were effective, but pads and cushions of the same material were less helpful.
Lectures complémentaires et références
- Bendezu RA, Mego M, Monclus E, et al; Contenu colique : effet du régime alimentaire, des repas et de la défécation. Neurogastroentérol Motil. Février 2017 ; 29(2). doi : 10.1111/nmo.12930. Publié en ligne le 21 août 2016.
- Malagelada JR, Accarino A, Azpiroz F; Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge. Am J Gastroenterol. 2017 Aug;112(8):1221-1231. doi: 10.1038/ajg.2017.129. Epub 2017 May 16.
- Kessing BF, Bredenoord AJ, Smout AJ; The pathophysiology, diagnosis and treatment of excessive belching symptoms. Am J Gastroenterol. 2014 Aug;109(8):1196-203); (Quiz) 1204. doi: 10.1038/ajg.2014.165. Epub 2014 Jul 8.
- Bredenoord AJ, Smout AJ; Physiologic and pathologic belching. Clin Gastroenterol Hepatol. 2007 Jul;5(7):772-5. doi: 10.1016/j.cgh.2007.02.018. Epub 2007 May 4.
- Hemmink GJ, Weusten BL, Bredenoord AJ, et al; Aerophagia: excessive air swallowing demonstrated by esophageal impedance monitoring. Clin Gastroenterol Hepatol. 2009 Oct;7(10):1127-9. doi: 10.1016/j.cgh.2009.06.029. Epub 2009 Aug 9.
- Bendezu RA, Barba E, Burri E, et al; Colonic content in health and its relation to functional gut symptoms. Neurogastroenterol Motil. 2016 Jun;28(6):849-54. doi: 10.1111/nmo.12782. Epub 2016 Feb 12.
- Major G, Pritchard S, Murray K, et al; Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology. 2017 Jan;152(1):124-133.e2. doi: 10.1053/j.gastro.2016.09.062. Epub 2016 Oct 14.
- Hemmink GJ, Ten Cate L, Bredenoord AJ, et al; Speech therapy in patients with excessive supragastric belching--a pilot study. Neurogastroenterol Motil. 2010 Jan;22(1):24-8, e2-3. doi: 10.1111/j.1365-2982.2009.01371.x. Epub 2009 Jul 27.
- ten Haaf DS, van der Worp MP, Groenewoud HM, et al; Nutritional indicators for gastrointestinal symptoms in female runners: the 'Marikenloop study'. BMJ Open. 2014 Aug 4;4(8):e005780. doi: 10.1136/bmjopen-2014-005780.
- Erdman KA, Jones KW, Madden RF, et al; Dietary Patterns in Runners with Gastrointestinal Disorders. Nutrients. 2021 Jan 29;13(2):448. doi: 10.3390/nu13020448.
- Cancer suspecté : reconnaissance et orientation; Directive NICE (2015 - dernière mise à jour avril 2026)
- Syndrome de l'intestin irritable chez les adultes : diagnostic et prise en charge du syndrome de l'intestin irritable en soins primaires; NICE Clinical Guideline (February 2008, updated April 2017)
- Ahmed JF, Padam P, Ruban A; Aetiology, diagnosis and management of small intestinal bacterial overgrowth. Frontline Gastroenterol. 2022 Jul 12;14(2):149-154. doi: 10.1136/flgastro-2022-102163. eCollection 2023.
- Blondeau K, Boecxstaens V, Rommel N, et al; Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching. Clin Gastroenterol Hepatol. 2012 Apr;10(4):379-84. doi: 10.1016/j.cgh.2011.10.042. Epub 2011 Nov 9.
- Bohn L, Storsrud S, Liljebo T, et al; Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015 Nov;149(6):1399-1407.e2. doi: 10.1053/j.gastro.2015.07.054. Epub 2015 Aug 5.
- Dale HF, Rasmussen SH, Asiller OO, et al; Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients. 2019 Sep 2;11(9). pii: nu11092048. doi: 10.3390/nu11092048.
- Policy guidance: conditions for which over the counter items should not be routinely prescribed in primary care. NHS England, 12 March 2024.
- Melchior C, Gourcerol G, Bridoux V, et al; Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial. PLoS One. 2017 Aug 1;12(8):e0180835. doi: 10.1371/journal.pone.0180835. eCollection 2017.
- Hillila M, Farkkila MA, Sipponen T, et al; Does oral alpha-galactosidase relieve irritable bowel symptoms? Scand J Gastroenterol. 2016 Jan;51(1):16-21. doi: 10.3109/00365521.2015.1063156. Epub 2015 Jul 2.
- Ohge H, Furne JK, Springfield J, et al; Effectiveness of devices purported to reduce flatus odor. Am J Gastroenterol. 2005 Feb;100(2):397-400.
Continuez à lire ci-dessous
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Prochaine révision prévue : 24 juin 2027
25 juin 2024 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement